Kristen V. Brown, a health staff writer for The Atlantic, dives into the rollercoaster ride of 23andMe, discussing its rise and current struggles. She highlights the privacy risks tied to genetic data and the implications of potential data misuse. The conversation reflects on how the company's initial appeal has dwindled due to market saturation and regulatory issues. With insights on data ownership and the challenges of consumer trust, Brown paints a compelling picture of the future of genetic testing.
Kristen V. Brown highlights the decline of 23andMe due to falling stock prices and decreased consumer trust amidst privacy concerns.
The podcast emphasizes the potential dangers of sharing genetic data, particularly regarding privacy and the misuse of personal information.
Deep dives
Personal Experience with DNA Testing
The conversation begins with the host discussing the personal journey of trying various DNA tests, as recounted by Kristen V. Brown. She highlights her extensive experience with over two dozen tests, including some obscure ones that even tested her cat's DNA. One particular test led to family complications when it mistakenly indicated Italian ancestry instead of her known Syrian heritage, illustrating the potential for misunderstandings in genealogy. Such tests often provide limited actionable insights about health risks, prompting questions about their overall value.
The Struggles of 23andMe
The current state of 23andMe is dire, with plummeting stock prices and significant operational challenges. The company has faced increased scrutiny from the FDA and has struggled to regain consumer trust following previous controversies. Changes in consumer sentiment, along with subsequent privacy concerns—especially following a data breach affecting millions—have led to a decline in test kit sales. The podcast examines how initial excitement surrounding personal genomics gave way to skepticism, as many realized that the health insights provided were often not as beneficial as anticipated.
Implications of Genetic Data Privacy
A discussion on the ramifications of genetic data illustrates the serious privacy concerns surrounding DNA testing companies. If 23andMe were to be sold, customer data would likely be treated as an asset, raising concerns about new terms of service that might not protect users' privacy. The potential for misuse of genetic data, showcased by previous breaches and government access, highlights the delicate balance between innovation and personal security. The podcast urges listeners to consider the broader implications of sharing such intimate genetic information, particularly in the context of evolving tech and privacy regulations.
Want more What Next TBD? Subscribe to Slate Plus to access ad-free listening to the whole What Next family and all your favorite Slate podcasts. Subscribe today on Apple Podcasts by clicking “Try Free” at the top of our show page. Sign up now at slate.com/whatnextplus to get access wherever you listen.
Podcast production by Evan Campbell, Patrick Fort, and Cheyna Roth.